PlainRecalls
FDA Devices Moderate Class II Ongoing

Atellica IM BR 27.29 (BR) Assay 250 Test Kit- in vitro diagnostic use in the quantitative serial determination of cancer antigen CA 27.29 in human serum and plasma (EDTA) using the Atellica IM Analyzer. SMN: 10995477

Reported: September 15, 2021 Initiated: July 6, 2021 #Z-2425-2021

Product Description

Atellica IM BR 27.29 (BR) Assay 250 Test Kit- in vitro diagnostic use in the quantitative serial determination of cancer antigen CA 27.29 in human serum and plasma (EDTA) using the Atellica IM Analyzer. SMN: 10995477

Reason for Recall

Product does not meet the Instructions for Use (IFU) claimed Pack Calibration Interval of 10 days. IFU calibration updated interval from 10 days to 3 days for all current and future kit lot numbers

Details

Units Affected
437 units
Distribution
Worldwide distribution. US Nationwide, Australia, Bahamas, India, Mexico, Saudi Arabia, and Viet Nam
Location
East Walpole, MA

Frequently Asked Questions

What product was recalled?
Atellica IM BR 27.29 (BR) Assay 250 Test Kit- in vitro diagnostic use in the quantitative serial determination of cancer antigen CA 27.29 in human serum and plasma (EDTA) using the Atellica IM Analyzer. SMN: 10995477. Recalled by Siemens Healthcare Diagnostics, Inc. Units affected: 437 units.
Why was this product recalled?
Product does not meet the Instructions for Use (IFU) claimed Pack Calibration Interval of 10 days. IFU calibration updated interval from 10 days to 3 days for all current and future kit lot numbers
Which agency issued this recall?
This recall was issued by the FDA Devices on September 15, 2021. Severity: Moderate. Recall number: Z-2425-2021.